(57 days)
The Precision Capillaries for Micromanipulation are microcapillaries intended for the following uses in assisted reproduction procedures:
- Holding human oocytes, blastocysts, or other suspension cells .
- Transferring and injecting sperm (or cells of a similar size) using the ICSI . (Intracytoplasmic Sperm Injection) technique
The proposed Precision Capillaries for Micromanipulation (Precision Capillaries) product line contains the following types of microcapillaries:
- VacuTips Holding Capillary, used for holding human oocytes, blastocysts, or ● other suspension cells
- TransferTips® (ICSI), used for transferring sperm and perforating oocytes . using the ICSI (Intracytoplasmic Sperm Injection) technique
The Precision Capillaries and the substantially equivalent devices are borosilicate glass microcapillaries designed for use in assisted reproduction procedures. The proximal end of the shaft is inserted into the capillary holder of the micromanipulator or microinjector. The distal end is drawn to a narrow tip that contacts the gamete for transfer and/or perforation. The distal end of the VacuTips is blunt for cell transfer. The TransferTips (ICSI) have spiked tips for perforation of the gamete. Three forms of the TransferTips (ICSI) are described in the 510(k), TransferTips-F, TransferTips-R, and TransferTips-RP. The TransferTips vary in shaft length, tip length, and flexibility of the flange.
Each Precision Capillary is mounted in a "Capillary Safe" consisting of a holder and protective tube to protect the capillary and the user during transport and handling. The Precision Capillary mounted in the Capillary Safe is sealed in a foil pouch to maintain sterility. The packaged devices are sterilized by gamma irradiation.
The provided text describes a 510(k) premarket notification for "Precision Capillaries for Micromanipulation." This document is focused on demonstrating substantial equivalence to predicate devices for assisted reproduction microtools, rather than detailing a study proving device performance against specific, quantifiable acceptance criteria in the way one might see for an AI/software device.
Therefore, many of the requested sections (sample sizes for test sets, expert qualifications, MRMC studies, standalone performance, training set details) are not applicable or not provided in the context of this type of submission.
However, I can extract the relevant information regarding performance testing and acceptance, even if not presented in a typical AI/medical device performance study format.
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Reported Device Performance | Comments |
|---|---|---|
| Biocompatibility/Safety | ||
| Bioburden Determination | Met safety standards | Implied as part of "test data obtained from these testing programs indicate that the Precision Capillaries are non-embryotoxic and nonpyrogenic." Specific numerical criteria not provided. |
| Endotoxin Determination | Non-pyrogenic | Specific numerical criteria not provided. |
| Embryotoxicity Testing | Non-embryotoxic | Specific numerical criteria not provided (e.g., cell viability percentage). |
| Functionality | ||
| Sperm Aspiration | Successfully aspirated sperm | Qualitative assessment; specific metrics/success rates not provided. |
| Oocyte Perforation (ICSI) | Easily perforated oocytes | Qualitative assessment; specific metrics/success rates not provided. |
| Sterility | Maintained Sterility | Achieved through gamma irradiation and sealed packaging. Specific sterility assurance level (SAL) not mentioned. |
| Packaging Integrity | Protected device and user | "Capillary Safe" protects during transport and handling. Specific packaging integrity tests (e.g., seal strength, burst tests) not detailed with acceptance criteria. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not specified in the document. The performance testing section mentions "biological and functional testing" and "application testing," but does not provide details on the number of capillaries, samples (e.g., sperm, oocytes), or replicates used for these tests.
- Data Provenance: Not explicitly stated. Given the context of a 510(k) submission by a U.S.-based sponsor (Brinkmann Instruments, Inc., Westbury, NY), it's highly probable the testing was conducted in a laboratory setting, likely within the U.S. The testing is reported retrospectively for this submission.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
Not applicable. The ground truth for functional tests (sperm aspiration, oocyte perforation) would be based on direct observation or laboratory measurements, not expert consensus in the typical sense of radiological or pathological interpretation. For biological safety tests, it would be based on established laboratory protocols and assays. No "experts" are mentioned for establishing ground truth.
4. Adjudication Method for the Test Set
Not applicable. This is not a study assessing human reader performance or diagnostic accuracy.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
Not applicable. This is a medical device (microcapillary), not an AI algorithm, and therefore, no MRMC study was conducted.
6. Standalone Performance (Algorithm Only without Human-in-the Loop Performance)
Not applicable. This is a physical medical device, not an algorithm.
7. Type of Ground Truth Used
- Laboratory Assay Results: For bioburden, endotoxin, and embryotoxicity testing.
- Direct Observation/Demonstration of Functionality: For successful sperm aspiration and oocyte perforation during "application testing."
8. Sample Size for the Training Set
Not applicable. This is a manufactured physical device, not a machine learning algorithm. There is no "training set" in this context. The product is manufactured and tested based on established design specifications.
9. How the Ground Truth for the Training Set Was Established
Not applicable. As above, there is no "training set." The device design and manufacturing processes are likely informed by predicate devices and engineering principles to ensure functionality and safety.
{0}------------------------------------------------
KO₂4302
510(k) Summary for
FEB 1 9 2003
Precision Capillaries for Micromanipulation
1. SPONSOR
Brinkmann Instruments, Inc. One Cantiague Road P.O. Box 1019 Westbury, NY 11590-0207
Contact Person: Joel Lopez Telephone: 516-515-2396
Date Prepared: December 23, 2002
2. DEVICE NAME
Proprietary Name: Precision Capillaries for Micromanipulation Common/Usual Name: Microcapillaries Assisted Reproduction Microtools Classification Name:
3. PREDICATE DEVICES
- . Scan-Med, Inc. (K991700), Swemed Intracytoplasmic Sperm Injection (ICSI) Micro-Injection Pipettes, Holding Pipettes, Denuding Pipettes, and Assisted Hatching/Zona Drilling Pipettes
- Humagen Fertility Diagnostics, Inc. (K990847), Intracytoplasmic Sperm ● Injection Micropipets (ICSI), Spermatid ICSI Micropipets, Holding Micropipets, Assisted Hatching Micropipets, Subzonal Injection Micropipets (SUZI), Partial Zona Dissection Micropipets (PZD), Denuding Micropipets
- Prodimed (K983713), Prodimed Microinjection Pipettes .
- Cook OB/GYN (K983596), Intracytoplasmic Sperm Injection (ICSI) Micro-. Injection Pipettes, Holding Pipettes, Denuding Pipettes, and Assisted Hatching /Zona Drilling Pipettes
{1}------------------------------------------------
4. DEVICE DESCRIPTION
The proposed Precision Capillaries for Micromanipulation (Precision Capillaries) product line contains the following types of microcapillaries:
- VacuTips Holding Capillary, used for holding human oocytes, blastocysts, or ● other suspension cells
- TransferTips® (ICSI), used for transferring sperm and perforating oocytes . using the ICSI (Intracytoplasmic Sperm Injection) technique
ર. INTENDED USE
The Precision Capillaries are microcapillaries intended for the following uses in assisted reproduction procedures:
- . Holding human oocytes, blastocysts, or other suspension cells
- Transferring and injecting sperm (or cells of a similar size) using the ICSI . (Intracytoplasmic Sperm Injection) technique
TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE 6.
The Precision Capillaries and the substantially equivalent devices are borosilicate glass microcapillaries designed for use in assisted reproduction procedures. The proximal end of the shaft is inserted into the capillary holder of the micromanipulator or microinjector. The distal end is drawn to a narrow tip that contacts the gamete for transfer and/or perforation. The distal end of the VacuTips is blunt for cell transfer. The TransferTips (ICSI) have spiked tips for perforation of the gamete. Three forms of the TransferTips (ICSI) are described in the 510(k), TransferTips-F, TransferTips-R, and TransferTips-RP. The TransferTips vary in shaft length, tip length, and flexibility of the flange.
Each Precision Capillary is mounted in a "Capillary Safe" consisting of a holder and protective tube to protect the capillary and the user during transport and handling. The Precision Capillary mounted in the Capillary Safe is sealed in a foil pouch to maintain sterility. The packaged devices are sterilized by gamma irradiation.
Differences between the proposed and predicate devices are limited to minor differences in design such as the length of the shaft, tip angle, the inner and outer
{2}------------------------------------------------
diameter of the tip, and the presence of a spike. These differences are minor and do not raise any new issues of safety or effectiveness.
7. PERFORMANCE TESTING
Biological and functional testing conducted to evaluate the safety and efficacy of the Precision Capillaries for their uses in assisted reproduction procedures includes bioburden determination, endotoxin determination, embryotoxicity testing, application testing, and packaging evaluation. The test data obtained from these testing programs indicate that the Precision Capillaries are non-embryotoxic and nonpyrogenic. The Precision Capillaries successfully aspirated sperm and easily perforated oocytes. These results demonstrate that the Precision Capillaries are safe and effective for their uses in assisted reproduction procedures.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of three human profiles facing to the right, with flowing lines suggesting movement or connection. The profiles are arranged in a way that they appear to be part of a larger, abstract shape. Encircling the image is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA".
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 1 9 2003
Brinkmann Instruments, Inc. % Cynthia J. M. Nolte, Ph.D. Medical Device Consultants, Inc. 49 Plain Street NORTH ATTLEBORO MA 02760 Re: K024302
Trade/Device Name: Precision Capillaries for Micromanipulation Regulation Number: 21 CFR 884.6130 Regulation Name: Assisted reproduction microtools Regulatory Class: II Product Code: 85 MQH Dated: December 23, 2002 Received: December 24, 2002
Dear Dr. Notle:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
{4}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of the letter:
| 8xx. 1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours.
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
510(k) Number (if known): ¥024302
Device Name: Precision Capillaries for Micromanipulation
Indications for Use:
The Precision Capillaries for Micromanipulation are microcapillaries intended for the following uses in assisted reproduction procedures:
- Holding human oocytes, blastocysts, or other suspension cells .
- Transferring and injecting sperm (or cells of a similar size) using the ICSI . (Intracytoplasmic Sperm Injection) technique
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NECESSARY)
Concurrence of CDRH, Office of Device Evaluation (ODE)
David G. Hagman
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use -----------------------------------------------------------------------------------------------
(Optional Format 1-2-96)
Brinkmann Instruments, Inc. 510(k) Precision Capillaries for Micromanipulation December 23, 2002
Page vii
§ 884.6130 Assisted reproduction microtools.
(a)
Identification. Assisted reproduction microtools are pipettes or other devices used in the laboratory to denude, micromanipulate, hold, or transfer human gametes or embryos for assisted hatching, intracytoplasmic sperm injection (ICSI), or other assisted reproduction methods.(b)
Classification. Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, and clinical testing). The device, when the assisted reproduction microtools (pipettes) are manufactured from glass, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.